Murphy Middleton Hinkle & Parker’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$887K Hold
35,016
0.5% 61
2025
Q1
$887K Sell
35,016
-2,642
-7% -$66.9K 0.5% 61
2024
Q4
$999K Sell
37,658
-1,561
-4% -$41.4K 0.56% 56
2024
Q3
$1.14M Sell
39,219
-912
-2% -$26.4K 0.61% 51
2024
Q2
$1.12M Sell
40,131
-820
-2% -$22.9K 0.65% 48
2024
Q1
$1.14M Sell
40,951
-1,211
-3% -$33.6K 0.66% 48
2023
Q4
$1.21M Sell
42,162
-5,252
-11% -$151K 0.75% 41
2023
Q3
$1.57M Buy
47,414
+811
+2% +$26.9K 1.01% 30
2023
Q2
$1.71M Sell
46,603
-1,466
-3% -$53.8K 1.07% 30
2023
Q1
$1.96M Buy
48,069
+4
+0% +$163 1.22% 28
2022
Q4
$2.46M Sell
48,065
-424
-0.9% -$21.7K 1.55% 21
2022
Q3
$2.12M Buy
48,489
+1,200
+3% +$52.5K 1.48% 23
2022
Q2
$2.48M Buy
47,289
+721
+2% +$37.8K 1.61% 19
2022
Q1
$2.41M Sell
46,568
-883
-2% -$45.7K 1.29% 23
2021
Q4
$2.8M Sell
47,451
-874
-2% -$51.6K 1.49% 18
2021
Q3
$2.08M Buy
48,325
+323
+0.7% +$13.9K 1.2% 27
2021
Q2
$1.88M Sell
48,002
-614
-1% -$24K 1.05% 32
2021
Q1
$1.76M Sell
48,616
-927
-2% -$33.6K 1.03% 35
2020
Q4
$1.82M Sell
49,543
-2,778
-5% -$102K 1.22% 27
2020
Q3
$1.82M Sell
52,321
-2,499
-5% -$87K 1.33% 22
2020
Q2
$1.7M Buy
54,820
+1,035
+2% +$32.1K 1.25% 24
2020
Q1
$1.67M Buy
53,785
+277
+0.5% +$8.58K 1.47% 23
2019
Q4
$1.99M Buy
53,508
+6
+0% +$223 1.32% 26
2019
Q3
$1.82M Sell
53,502
-169
-0.3% -$5.76K 1.29% 26
2019
Q2
$2.21M Sell
53,671
-964
-2% -$39.6K 1.57% 20
2019
Q1
$2.2M Sell
54,635
-156
-0.3% -$6.29K 1.51% 20
2018
Q4
$2.27M Sell
54,791
-2,385
-4% -$98.8K 1.73% 17
2018
Q3
$2.39M Buy
57,176
+4
+0% +$167 1.69% 14
2018
Q2
$1.97M Buy
57,172
+6
+0% +$207 1.47% 20
2018
Q1
$1.93M Sell
57,166
-848
-1% -$28.6K 1.5% 22
2017
Q4
$1.99M Buy
+58,014
New +$1.99M 1.48% 23